Literature DB >> 6735480

Prevalence of hepatitis B virus infection in out-patient alcoholics.

C Gluud, B Gluud, J Aldershvile, A Jacobsen, O Dietrichson.   

Abstract

Sera from 192 out-patient alcoholics attending a clinic for the treatment of alcoholism were tested for hepatitis B surface antigen (HBsAg) and for antibodies to HBsAg and to hepatitis B core antigen (HBcAg). Three sera (1.5%) were positive for HBsAg. Of the remaining 189 alcoholics, 29 (15%) were positive for one or both antibodies. This prevalence is not significantly different from that found in 137 hospitalized HBsAg-negative patients with alcoholic liver disease (35/137 [26%] were positive for one or both antibodies). However, the prevalence of hepatitis B antibodies in out-patient alcoholics is significantly (p less than 0.01) higher when compared with the prevalence in healthy volunteer blood donors (5/114 [4%] were positive for one or both antibodies). A comparison of out-patient alcoholics positive for one or both antibodies (n = 29) with patients negative for both antibodies (n = 160) revealed that the median age in the former group (46 years) was significantly (p less than 0.05) higher than that in the latter group (40 years).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735480     DOI: 10.1007/BF01641674

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Limitations of the application of fourfold table analysis to hospital data.

Authors:  J BERKSON
Journal:  Biometrics       Date:  1946-06       Impact factor: 2.571

2.  Hepatitis-associated antigen in pregnant women.

Authors:  P Skinhoj; H Olesen; J Cohn; M Mikkelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

3.  Detection of antibody to hepatitis-associated antigen in hemophilia patients and in voluntary blood donors.

Authors:  M R Peterson; L F Barker; D S Schade
Journal:  Vox Sang       Date:  1973-01       Impact factor: 2.144

4.  Hepatitis B antigen and antibody in blood donors: an epidemiologic study.

Authors:  W Szmuness; A M Prince; B Brotman; R L Hirsch
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

5.  Hepatitis Bs antibody in alcoholic cirrhosis.

Authors:  P R Mills; T H Pennington; P Kay; R N MacSween; G Watkinson
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

6.  Evidence for previous hepatitis B virus infection in alcoholic cirrhosis.

Authors:  P R Mills; E A Follett; G E Urquhart; G Clements; G Watkinson; R N Macsween
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

7.  Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey.

Authors:  W S Hislop; E A Follett; I A Bouchier; R N MacSween
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

8.  Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage.

Authors:  E Villa; L Rubbiani; T Barchi; I Ferretti; A Grisendi; M De Palma; S Bellentani; F Manenti
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

9.  Hepatitis B and A virus antibodies in alcoholic steatosis and cirrhosis.

Authors:  C Gluud; J Aldershvile; J Henriksen; P Kryger; L Mathiesen
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

10.  Prevalence of hepatitis B virus infection among alcoholic patients with liver disease.

Authors:  M Orholm; J Aldershvile; U Tage-Jensen; P Schlichting; J O Nielsen; F Hardt; P Christoffersen
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

View more
  2 in total

1.  Hepatic lesions in alcoholic HBV carriers.

Authors:  T Takahashi; T Kamimura; H Asakura; F Ichida
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: low incidence of HCV infection.

Authors:  G N Dalekos; E Zervou; M H Merkouropoulos; E V Tsianos
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.